The infectious consequences of rituximab addition to fludarabine-containing regimens

Blood. 2006 Apr 1;107(7):3013-4. doi: 10.1182/blood-2005-10-4012.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Clinical Trials, Phase II as Topic
  • Drug Interactions
  • Humans
  • Lymphoma, AIDS-Related / drug therapy*
  • Rituximab
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
  • Vidarabine
  • fludarabine